Zoetis Net Income 2011-2018 | ZTS

Zoetis annual/quarterly net income history and growth rate from 2011 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Zoetis net income for the quarter ending December 31, 2018 was $0.345B, a 325.93% increase year-over-year.
  • Zoetis net income for the twelve months ending December 31, 2018 was $1.428B, a 65.28% increase year-over-year.
  • Zoetis annual net income for 2018 was $1.428B, a 65.28% increase from 2017.
  • Zoetis annual net income for 2017 was $0.864B, a 5.24% increase from 2016.
  • Zoetis annual net income for 2016 was $0.821B, a 142.18% increase from 2015.
Zoetis Annual Net Income
(Millions of US $)
2018 $1,428
2017 $864
2016 $821
2015 $339
2014 $583
2013 $504
2012 $436
2011 $245
2010 $110
Zoetis Quarterly Net Income
(Millions of US $)
Q4 2018 $345
Q3 2018 $347
Q2 2018 $384
Q1 2018 $352
Q4 2017 $81
Q3 2017 $298
Q2 2017 $247
Q1 2017 $238
Q4 2016 $154
Q3 2016 $239
Q2 2016 $224
Q1 2016 $204
Q4 2015 $22
Q3 2015 $189
Q2 2015 $-37
Q1 2015 $165
Q4 2014 $126
Q3 2014 $166
Q2 2014 $136
Q1 2014 $155
Q4 2013 $105
Q3 2013 $131
Q2 2013 $128
Q1 2013 $140
Q4 2012 $-10
Q3 2012 $162
Q2 2012 $173
Q1 2012 $111
Q4 2011 $0
Q4 2010 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $48.866B $5.825B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $28.763B 10.64
Grifols (GRFS) Spain $13.022B 15.92
Ionis Pharmaceuticals (IONS) United States $10.380B 32.19
Sage Therapeutics (SAGE) United States $7.864B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.405B 10.60
Neurocrine Biosciences (NBIX) United States $7.366B 474.77
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.505B 8.78
Tilray (TLRY) United States $4.865B 0.00
United Therapeutics (UTHR) United States $4.561B 7.76
Taro Pharmaceutical Industries (TARO) Israel $4.165B 13.41
FibroGen (FGEN) United States $4.101B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.841B 0.00
Portola Pharmaceuticals (PTLA) United States $2.408B 0.00
PTC Therapeutics (PTCT) United States $2.130B 0.00
USANA Health Sciences (USNA) United States $1.922B 16.12
Heron Therapeutics (HRTX) United States $1.884B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.856B 0.00
Xencor (XNCR) United States $1.836B 0.00
Aerie Pharmaceuticals (AERI) United States $1.814B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.734B 21.60
Madrigal Pharmaceuticals (MDGL) United States $1.685B 0.00
Endo (ENDP) Ireland $1.656B 2.55
Pacira Pharmaceuticals (PCRX) United States $1.617B 139.82
Zogenix (ZGNX) United States $1.586B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.385B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.171B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.079B 0.00
TherapeuticsMD (TXMD) United States $1.008B 0.00
Radius Health (RDUS) United States $0.995B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.898B 0.00
Akebia Therapeutics (AKBA) United States $0.781B 0.00
CannTrust Holdings (CTST) Canada $0.767B 0.00
ChemoCentryx (CCXI) United States $0.738B 0.00
ArQule (ARQL) United States $0.713B 0.00
Dermira (DERM) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.604B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
Forty Seven (FTSV) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
GlycoMimetics (GLYC) United States $0.562B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.555B 0.00
Collegium Pharmaceutical (COLL) United States $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 24.03
TCR2 THERAPTCS (TCRR) United States $0.450B 0.00
KalVista Pharmaceuticals (KALV) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.437B 0.00
OptiNose (OPTN) United States $0.418B 0.00
Flexion Therapeutics (FLXN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.393B 0.00
Aptorum Group (APM) China $0.389B 0.00
Mast Therapeutics (SVRA) United States $0.383B 0.00
ImmunoGen (IMGN) United States $0.375B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Karyopharm Therapeutics (KPTI) United States $0.303B 0.00
Minerva Neurosciences (NERV) United States $0.287B 0.00
Harpoon Therapy (HARP) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.283B 2.63
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.280B 10.38
AcelRx Pharmaceuticals (ACRX) United States $0.276B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Aclaris Therapeutics (ACRS) United States $0.258B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.246B 0.00
Dova Pharmaceuticals (DOVA) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Concert Pharmaceuticals (CNCE) United States $0.227B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Ardelyx (ARDX) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.206B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.204B 0.00
Affimed (AFMD) Germany $0.203B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 190.00
Majesco Entertainment (PTE) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
ElectroCore (ECOR) United States $0.176B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.169B 0.00
Ocular Therapeutix (OCUL) United States $0.165B 0.00
IMV INC (IMV) Canada $0.165B 0.00
Tyme Technologies (TYME) United States $0.163B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
MediWound (MDWD) Israel $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
China SXT Pharmaceuticals (SXTC) China $0.120B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Neos Therapeutics (NEOS) United States $0.115B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Oasmia Pharmaceutical AB (OASM) Sweden $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
DURECT (DRRX) United States $0.092B 0.00
Zafgen (ZFGN) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.041B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 3.62
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Shineco (TYHT) China $0.027B 4.58
PharmAthene (ALT) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.76
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Achaogen (AKAO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00